Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 556

Similar articles for PubMed (Select 17038631)

1.

Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.

Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):190-6. Epub 2006 Oct 12.

2.

Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.

Vikstedt R, Ye D, Metso J, Hildebrand RB, Van Berkel TJ, Ehnholm C, Jauhiainen M, Van Eck M.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):578-86. Epub 2006 Dec 14.

3.

Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.

Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1572-8. Epub 2006 May 4.

4.

Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Yeang C, Qin S, Chen K, Wang DQ, Jiang XC.

J Lipid Res. 2010 Oct;51(10):2993-3002. doi: 10.1194/jlr.M007088. Epub 2010 Jun 11.

5.

Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.

Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1277-82. doi: 10.1161/ATVBAHA.108.165084. Epub 2008 Apr 17.

6.
7.

Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.

Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF.

Circulation. 2003 Nov 4;108(18):2258-63. Epub 2003 Oct 27.

8.

Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells.

Lee-Rueckert M, Vikstedt R, Metso J, Ehnholm C, Kovanen PT, Jauhiainen M.

J Lipid Res. 2006 Aug;47(8):1725-32. Epub 2006 May 10.

9.

Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency.

Valenta DT, Bulgrien JJ, Bonnet DJ, Curtiss LK.

J Lipid Res. 2008 Jan;49(1):24-32. Epub 2007 Oct 10.

10.

Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.

Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E284-90. Epub 2007 Nov 20.

11.

Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.

van Haperen R, Samyn H, Moerland M, van Gent T, Peeters M, Grosveld F, van Tol A, de Crom R.

PLoS One. 2008 May 28;3(5):e2255. doi: 10.1371/journal.pone.0002255.

12.

Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.

Su YR, Dove DE, Major AS, Hasty AH, Boone B, Linton MF, Fazio S.

Circulation. 2005 May 10;111(18):2373-81. Epub 2005 Apr 25.

13.
14.

Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.

Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4647-52.

15.

Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.

van Haperen R, van Gent T, van Tol A, de Crom R.

Atherosclerosis. 2013 Mar;227(1):37-42. doi: 10.1016/j.atherosclerosis.2012.11.022. Epub 2012 Dec 12.

16.

Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.

Van Eck M, Herijgers N, Yates J, Pearce NJ, Hoogerbrugge PM, Groot PH, Van Berkel TJ.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3117-26.

17.

Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.

Yang XP, Yan D, Qiao C, Liu RJ, Chen JG, Li J, Schneider M, Lagrost L, Xiao X, Jiang XC.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1601-7. Epub 2003 Jul 10.

18.

Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.

Ranalletta M, Wang N, Han S, Yvan-Charvet L, Welch C, Tall AR.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2308-15. Epub 2006 Aug 17.

19.

Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.

Tangirala RK, Praticó D, FitzGerald GA, Chun S, Tsukamoto K, Maugeais C, Usher DC, Puré E, Rader DJ.

J Biol Chem. 2001 Jan 5;276(1):261-6.

20.

Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE.

J Clin Invest. 1995 Nov;96(5):2170-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk